Introduction
Currently, ethical and scientific issues surrounding embryonic and fetal stem cells hinder their widespread implementation. In contrast cells recovered post-natally from umbilical cord are readily available, inexpensive and inexhaustible source of stem cells. 1 At least two types of stem cells have been found in the human umbilical cord (UC) so far; the hematopoietic stem cells (HSCs) and the mesenchymal stem cells (MSCs). Umbilical cord blood (UCB) is a fairly good source of pluripotent MSCs and HSCs with lineage specificity 2 and hence is rapidly gaining attention for its proposed therapeutic values. 3, 4 The UCB derived MSCs also exhibit the potential to differentiate into the insulin producing beta cells [5] [6] [7] [8] and hence can be used as an alternative for pancreatic progenitor cells. However the availability of cord blood will be limited in due course of time, as most of the cord blood would be cryopreserved for banking purposes; hence there is a dire need to look for an alternative source of stem cells. It has been shown that the UC matrix-'Wharton's jelly' is a far richer source of MSCs Islet neogenesis from the constitutively nestin expressing human umbilical cord matrix derived mesenchymal stem cells sachin s. Kadam and Ramesh R. Bhonde* Tissue engineering and Banking Laboratory; National center for cell science; Ganeshkhind, pune India
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In recent years, several reports on cord stromal cells describe their mesenchymal characters and applications in a variety of therapeutics. [10] [11] [12] [13] The MSCs derived from the Wharton's jelly are multipotent, with high proliferation capabilities and do not induce teratomas post-transplantation. 14 The ability of human umbilical cord matrix stem cells (hUCMSCs) to differentiate into adipogenic, chondrogenic, osteogenic as well as neuronal and cardiomyogenic lineages [15] [16] [17] has been documented. Other studies have shown that these hUCMSCs express nestin as a mesenchymal marker and can also be successfully differentiated into functional neurons. 10, 18, 19 Nestin positive stem cells isolated from adult pancreatic islets have been shown to differentiate ex vivo into pancreatic endocrine, exocrine and hepatic phenotypes. 20 Endocrine cell development has been correlated with frequency of nestin positive progenitors within pancreatic ducts and islets of rat, further emphasizing the importance of nestin positive progenitors in islet neogenesis. 21 The scarcity of islets for transplantation calls for an alternative sources of islets. The human umbilical cord has been shown to be a reservoir of multipotent stem cells with capacity to differentiate into ectodermal, mesodermal and endodermal lineages. The present investigation deals with isolation and characterization of mesenchymal stem cells (Msc) derived from human umbilical cord and their differentiation into functional islets. since these Mscs were found to constitutively express nestin we hypothesized that these would be ideal candidates for islet neogenesis without any further manipulation. human umbilical cord matrix stem cells (hUcMscs) were found to express cD29, cD44, cD73, cD90, cD117, smooth muscle actin, nestin, vimentin, proliferation marker Ki67 and embryonic markers Oct4, sseA4. These were found to be negative for cD33, cD34, cD45 and hLA DR. human UcMscs exhibited high proliferating capacity for extended period indicating potential for scaling up. When subjected to a cocktail of specific differentiating factors, these cells differentiated into fat, cartilage, bone, neurons and islet like clusters (ILcs). These ILcs stained positive for diphenylthiocarbazone (DTZ) and expressed human c-peptide, insulin and glucagon. Real time qpcR analysis of newly generated islets further demonstrated abundance of pdx-1, Ngn3, insulin, glucagon and somatostatin transcripts. On transplantation in experimental diabetic mice these ILcs restored normoglycemia, body weight and exhibited normal glucose tolerance test indicating their functional status. Thus, the present study demonstrates potential of constitutively expressing nestin positive progenitor from umbilical cord as a novel source for islet neogenesis and their usage in cell replacement therapy for diabetes.
Recently, the potential of Wharton's jelly derived MSCs to differentiate into islet like clusters (ILCs) has attracted the interest of several beta cell researchers. 22 However, the time consuming protocol for obtaining ILCs from Wharton's jelly derived MSCs after inducing them with rat brain extract to induce expression of nestin, may limit their use in human transplantation.
We therefore undertook the present study to isolate hUCMSCs which constitutively express nestin and to induce their These partial and fully differentiated ILCs (day 4 and day 10 respectively) when analyzed for the pancreas specific transcription factors by Taqman based real-time PCR, day 4 ILCs demonstrate abundance of Pdx-1 and Ngn-3 genes required for islet development. While day 10 mature ILCs showed abundance of insulin glucagon, somatostatin transcripts. These genes were absent in undifferentiated hUCMSCs (Fig. 4F) .
Islet like clusters transplantation to STZ induced diabetic animals reduced hyperglycemia. Diabetic mice without transplantation showed hyperglycemia through out the study period and died after 20 days. Non transplanted-non diabetic mice showed normal BG values. ILCs transplanted mice showed reduction in BG levels and reversal of experimental diabetes after 15 days, which were maintained at less than 140 mg/dL. Mice transplanted with undifferentiated cord MSCs does not restore normoglycemia and died after day 15 (Fig. 5C) . Gradual increase in body weight of ILC Tx, Sham Tx and negative control group mice was observed (Fig. 5D) . A standard two hours intraperitoneal glucose tolerance test showed and the bell shaped curve was observed when plotted time vs. blood glucose (Fig. 5E ). There was no significant difference between ILC transplanted mice vs. negative control when subjected to intraperitoneal glucose tolerance test (IPGTT) (Fig. 5F) .
Within three days of surgical removal of biocompatible capsule hyperglycemia was observed and all mice died within 2 weeks.
Discussion
In present study we have shown large scale isolation, long term maintenance and the multilineage differentiation potential of hUCMSCs including pancreatic lineage. The protocol for isolation of hUCMSCs has been improvised in terms of enzymes used for digestion. 23 Cocktail of collagenase, dispase and trypsin-EDTA helped in reduction of digestion time with increased cell yield and high reproducibility. Digestion with collagenase alone for 18 h resulted in large mucous accumulation leading to loss in the cell yield. Our lab has reported 24 earlier that hUCBS supports attachment, propagation and differentiation of human bone marrow derived mesenchymal cells, which was further confirmed by Shetty et al. 25 Hence the hUCMSCs were supplemented by hUCBS instead of the fetal calf serum for better proliferation. We purposefully avoided the use of FCS in order to grow the cells in medium free of xenoproteins to make them suitable for human transplantation studies. Human UCMSCs have been cultured for more that 25 population doublings without any change in the morphology, MSC characteristics and differentiation potential. The data obtained on the morphological features clearly indicate mesenchymal nature as opposed to fibroblast and these studies are in agreement with those of Nanaev et al., Takechi et al. and Yarygin et al. [26] [27] [28] The ROS form as a natural by-product of normal metabolism of oxygen in cells and shows elevated levels during the environmental stress. Hence, to determine the cryopreservation stress on cells the ROS generation before and after cryopreservation was studied. The negligible difference in ROS generation indicates Alizarin red S stain indicating direct evidence of calcium deposits as amorphous accumulation between cells ( When expose to neuronal differentiation cocktail medium for 21 days, hUCMSCs change their morphology to neuronal cell. These cells stain positive for neuronal markers Map2 and NeuN (Fig. 3D) .
Differentiation to islets like cluster and their functional study. The induction of hUCMSCs with serum free medium containing cocktail of ITS, nicotinamide, taurine have microscopically showed the progressive cell clustering from day 2 onwards which led to typical islets like clusters (ILCs) formation at the end of day 10 ( Fig. 4A) . After 10 days of induction these mature ILC clusters stained positive for the islet-specific DTZ stain (Fig. 4B) , which is known to selectively stain pancreatic beta cells because of their high zinc content, non-islet tissue remained unstained. These clusters were also found positive for insulin, glucagon (Fig. 4C) by immunocytochemistry.
These newly generated ILCs showed insulin secretion upon glucose stimulation. Basal insulin secretion was observed around 20 mU/mL and, around 65 mU/mL for stimulated insulin secretion, while second low glucose stimulation showed similar values to the basal insulin secretion (Fig. 4D) . C-peptide secretion in day 10 ILC culture supernatant was observed to be 73 pmol/L (Fig. 4E) . While amylase secretion by these ILCs in day 0, day 2, day 4 and day 10 culture supernatant was undetectable (data not shown). Though, Chao et al. 22 showed the differentiation of Wharton's jelly derived MSCs into ILCs their protocol of isolation of these MSCs is lengthy, (18 h digestion protocol) and therefore time consuming. Since the hUCMSCs isolated in present study constitutively express nestin as shown by our present data (Fig. 2C) and as well as previous reports, 10, 19 we did not find it necessary to use neuronal conditioned medium as reported by Chao et al. 22 Moreover correlation between nestin positive stem cells with endocrine development 20, 21 brings out the importance of nestin in MSCs making them prospective candidates for islet neogenesis. Our protocol of islet differentiation involves time dependant sequential addition of ITS, taurin, nicotinamide and GLP1 in a serum free medium leading to formation of mature islets expressing all the islet hormones at the end of day 10 eliminating the need of stem cell conditioned medium reported earlier. 22 The islets obtained were found to be responsive to glucose challenge as evidenced by around three-fold increase in insulin secretion over basal stimulation (Fig. 4A) indicating ability of the islet generated to synthesize, store and release insulin in response to glucose challenge.
In our initial study, we have tried transplantation of undifferentiated hUCMSCs and the newly formed ILCs under kidney that the isolated hUCMSCs withstands the cryopreservation stress (Fig. 1C) .
The immunofluorescence study for specific cell surface markers clearly indicate that isolated human UC cells are positive for mesenchymal proteins SMA, vimentin, nestin, desmin; proliferation marker Ki67; surface markers CD29, CD44, CD73, CD90, CD117 and negative for CD45, CD34, CD105 confirming their identity as MSCs. Presence of nestin as a MSC marker has been reported earlier 10, 19, 23 supporting our present data demonstrating constitutive expression of nestin in hUCMSCs. Like bone marrow MSCs these hUCMSCs also exhibited presence of embryonic cell markers SSEA4, 29 and oct4 by immunocytochemistry as reported previously. 30 Presence of oct4 and SSEA4 make hUCMSCs a connecting link between embryonic stem cells and adult stem cells making them more vulnerable for differentiating into functional islets as evidenced by present studies. The multipotent nature of these cells is reveled by their differentiation into adipogenic, chondrogenic, osteogenic and neuronal cell lineage (Fig. 3A-D respectively) . In addition to this, our studies also demonstrate the potential of hUCMSCs to differentiate into islet lineage (Fig. 3E) . The identity of newly generated ILCs has been confirmed to be islets as evidenced by immunoflurescence for insulin, glucagon, C-peptide and DTZ staining which is highly specific for islets. Presence of beta cell developmental transcripts like Pdx-1, Ngn-3 in day 4 ILCs and proinsulin and glucagon In nutshell, the present study clearly documents potential of hUCMSCs to differentiate into islets offering yet another non pancreatic, readily available, non-invasive and inexhaustible source of stem cells for islet generation.
Materials and Methods
The work was conducted following the approval from the National Centre for Cell Science (NCCS) Institutional Ethical Committee.
Sample collection. Human UC of spontaneous vaginal deliveries, forceps assisted deliveries as well as segment cesarean section deliveries of term pregnancies were collected after receiving an informed written consent of the parents. Collected cords were aseptically stored and transported at ambient temperature to the lab in L15 collection medium. The cord blood was drained and clots were flushed from the vessels using sterile phosphate buffer saline (PBS). After cleaning, the umbilical cord was processed for the isolation of hUCMSCs.
Isolation and expansion of human umbilical cord mesenchymal stem cells (hUCMSCs).
To isolate hUCMSCs, blood vessels from the UC were removed by blunt dissection and remaining portion of the cord was chopped into pieces of 1-2 mm length using sterile surgical blade. The tissue was then digested for 30 min in an enzyme cocktail (Collagenase Type IV: Dispase, 7:1 v/v) (Sigma Aldrich, St. Louis, MO; Boehringer Mannheim, Penzberg, capsule into STZ diabetic mice. Mice transplanted with ILCs from hUCMSCs into Kidney capsules showed the reversal of hyperglycemia without any signs of immune rejections of graft and teratomas formation which is in accordance with earlier reports. 1, 13, 14, 31, 32 However, the histopathology of transplanted kidney graft showed disintegration of ILCs to mesenchymal cells (data not shown). Hence we have later used immunoisolatory biocompatible capsules for the transplantation of ILCs generated from human tissue into mice (xenotransplantation).
ILC transplanted mice demonstrated significant reduction in hyperglycemia and increase in body weight when compared to undifferentiated hUCMSCs transplantation. This indicates functional status of ILCs. IPGTT performed on ILCs transplanted hyperglycemic mice further documents reversal of experimental diabetes. The normal IPGTT of islet like cell clusters in macrocapsules, indicates proper glucose sensing and insulin release even when they are encapsulated. Hence, we can conclude that the macrocapsule membrane allow the passage of low molecular weight substances (mainly glucose and insulin) through the capsular membrane but not of immunocytes and other transplant rejection effector molecules. 33 The achieved normoglycemic condition was maintained for 3 months follow up before terminating the experiment. Recurrence of hyperglycemia on surgical retrieval of transplanted capsule after three months confirms the normal blood glucose concentrations in transplanted mice were due to the hUCMSCs derived ILC graft. Human UCMSCs at passage 3 were fed with alternate cycle of adipogenic induction medium (PT-3102B Cambrex, Walkersville, MD) and adipogenic maintenance medium (PT-3102A Cambrex, Walkersville, MD), adipogenesis was induced as per the manufactures instruction. Adipogenesis was confirmed using Oil Red O staining.
For chondrogenic, osteogenic and neuronal differentiation, 3 x 10 3 hUCMSCs/cm 2 were plated onto tissue culture flasks and cells were allowed to adhere to culture surface for 24 h at 37°C. Chondrogenic, osteogenic and neuronal lineages were induced by replacing the growth medium (DMEM:HF12; 1:1) with chondrogenic, osteogenic and neuronal differentiation bullet kit (PT-3003, PT-3002 and CC-3229 respectively Cambrex, Walkersville, MD) respectively as per manufacture's instructions. Chondrogenesis was confirmed using Safranin-O staining; osteogenesis by staining with Alizarin Red S while neuronal differentiation was confirmed by immunostaining with neuron specific markers Map2 and NeuN (Chemicon, Temecula, CA).
Differentiation to islets like cluster (ILCs). The hUCMSCs on reaching 80% confluency were seeded in serum free medium (SFM) [DMEM:HF12, 1:1; insulin, transferrin and selenium (ITS)] for 72 h at 37°C. By day 3 hUCMSCs start forming cell aggregates. On day 4 SFM was supplemented with 0.3 mM taurine. On day 10 these ILCs were induced with a mixture of 100 mM nicotinamide, 3 mM taurine and 100 nM glucagon like peptide 1 (GLP1). 33, 34 The floating islets were collected and used for in vitro and in vivo characterization and functional studies.
Characterization of ILCs using diphenylthiocarbazone staining. Specificity of ILCs were determined by Diphenylthiocarbazone (DTZ) staining. 35 ILCs were incubated with 10 µL DTZ stain for 1 h at 37°C and viewed under inverted phase contrast microscope (Olympus IX 70, Tokyo, Japan).
Assessment of ILCs for the presence of pro-insulin and glucagon. cDNA was prepared from RNA isolated from hUCMSCs and day 4 (intermediate stage of ILCs development) and day 10 (developed) ILCs using 'High Capacity cDNA archive kit' (Applied Biosystems, Foster City, CA). The 100 ng cDNA was used for reverse transcription/quantitative real-time PCR using a 7500 FAST real-time PCR cycler (Applied Biosystems, Foster City, CA). Primers and probes were Assay-on-Demand (Applied Biosystems, Foster City, CA). All qRT-PCR results were normalized to 18S (VIC-labeled) ribosomal RNA carried out in duplex reaction (with FAM labeled target gene probes) to correct for any differences in RNA input. The relative gene expression profile was compared with that of undifferentiated hUCMSCs.
Insulin release and C-peptide assay. 100 ILCs were handpicked and incubated with 200 µL Krebs Ringer Bicarbonate Buffer (pH 7.4) supplemented with 10 mM/L HEPES (now called KRBH) and 5.5 mM glucose at 37°C for 1 h. Supernatant was then collected and stored at -80°C. ILCs were then transferred to KRBH supplemented with 16.5 mM glucose. After incubating them for 1 h at 37°C, the supernatant was collected and stored at -80°C. Secreted insulin was quantified using Insulin ELISA kit (sensitivity: 0.07 mU/L) (Mercodia, AB, Sweden). For stage specific C-peptide assay during ILC development, conditioned medium was collected at each time point from all experimental Germany, respectively) on a magnetic orbital shaker at 37°C. Tissue was then transferred to a mixture of trypsin (0.05%) and EDTA (0.02%) (Sigma Aldrich, St. Louis, MO) and was further incubated for 15-20 min as before. The homogenate was then filtered using sterile muslin cloth and cell pellet was obtained by centrifuging the filtrate at 1,500 rpm for 10 min. Finally, the cells were washed and cultured in Dulbeco's Modified Eagles Medium and Ham's F12 (DMEM:HF12; 1:1) medium (Invitrogen, Carlsbad, CA), supplemented with penicillin (100 units/mL), streptomycin (100 µg/mL) and 10% human umbilical cord blood serum (hUCBS) and incubated for 48 h at 37°C and 5% CO 2 .
Medium was changed every 48 h and replenished with DMEM:HF12 (1:1) supplemented with 10% hUCBS. Cells were first passaged after 8 days and then after every 4 days. Cell growth was analyzed by direct cell count to determine the log, lag and stationary phases. For this the cells were seeded onto 12 well tissue culture dish at the density 5 x 10 3 cell/cm 2 . Viable cells were counted using the trypan blue dye exclusion test every 48 h.
Isolated cells were cryopreserved using 10% DMSO standard protocol. The stress on cells before and after cryopreservation was studied by 10 min incubation with 10 µM dichlolrodihydrofluorescin diacetate (DCFH-DA) (Sigma Aldrich, St. Louis, MO). The resulting fluorescence was measured at an excitation 438 nm and emission 510 nm using Fluoroskan ® Ascent FL fluorometer (Thermo Fisher Scientific, Hudson, NH). Values were corrected by subtracting auto-fluorescence for respective groups.
Characterization of isolated cells using immunocytochemistry and flow cytometry. The cells from early passages (4-6) were used for the characterization studies. Cells were grown in monolayers on coverslips and were fixed using 4% paraformaldehyde. The cells were then permiabilized using 50% methanol for 5 min followed by blocking using 5% Bovine Serum Albumin (BSA) in PBS for 1 h. The cells were then exposed to nestin, vimentin, desmin, smooth muscle actin, Ki67 and SSEA4 primary non-labeled mouse anti-human antibodies (1:100 dilutions) (Chemicon, Temecula, CA) for 12 h at 4°C, followed by respective secondary antibodies (Invitrogen, Carlsbad, CA) for 1 h at 37°C. The coverslips were mounted in mounting medium containing antifade (Vectashield, Vector Laboratory, Burlingame, CA) and 4',6-diamidoino-2-phenylindole (DAPI) (Invitrogen, Carlsbad, CA). The slides were then viewed using confocal laser scanning microscope-LSM 510 Zeiss workstation (Carl Zeiss Meditec AG, Jena, Germany). DAPI was used for nuclei visualization.
The cells from the passage 4-6 were dislodged using 0.05% trypsin 0.02% EDTA in PBS and resuspended in DMEM:HF12 (1:1). The cells were fixed in chilled 70% ethanol and incubated in mouse anti human FITC/PE conjugated antibodies against Oct4, CD29, CD33, CD34, CD44, CD45, CD73, CD90, CD105, CD117 and HLA DR (1:100 dilution) for 1 h on ice (all the antibodies were purchased from Becton Dickinson, San Diego, CA). The cells were acquired using a BD-FACS Vantage flow cytometer with laser 488 nm (Becton Dickinson, NJ) and data was analyzed using BD Cellquest Pro software.
Differentiation studies. Induction of adipogenic, chondrogenic, osteogenic and neuronal differentiation:
on the abdomen and a macrocapsule with or without islets, was introduced (Fig. 5B) . Animals in the experimental group (ILC Tx) received capsules packed with ILCs, Second group of diabetic animals was transplanted with capsule containing undifferentiated hUCMSCs (3 x 10 6 ) (hUCMSCs Tx), and third group consisted of diabetic control/sham transplanted (sham Tx) animals; received an equivalent number of empty capsules. Nontransplanted diabetic animals were considered as positive control while non-diabetic untreated animals were considered as untreated control. Total six animals were studied per group. Incisions were sutured using absorbable 6-0 catgut sutures (Stericat Gutstrings, Delhi) and autoclipper (Becton Dickinson, Bedford, USA). All animals (control and experimental) received an i.p. injection of gentamycin (3 mg/kg body weight), Ampicillin and cloxacillin (20 mg/kg body weight) and Diclofenac sodium (0.5 mg/kg body weight), for 3 days (starting from the day of operation) in addition to the topical ointments (Soframycin).
BG and body weights were monitored for all groups after every 48 h (while values for every 7 th day have been represented). After one month of transplantation, animals from ILC Tx group and undifferentiated hUCMSCs group were subjected to intraperitoneal glucose tolerance test (IPGTT) as per the standard protocol.
At the end of the observation period (3 months) all the biocompatible capsules were surgically removed and animals were observed for blood glucose concentrations.
Statistical analysis. IPGTT data points were collected in triplicates and calculated as mean ± standard deviations. The student t-test was applied to compare the level of significance between the three groups. For all statistical testes, a value of p < 0.05 was considered to be statistically significant difference.
groups and quantified using Ultra-sensitive C-peptide human ELISA kit (sensitivity: 1.5 pmol/L) (Mercodia, AB, Sweden).
ILCs transplantation into STZ-induced diabetic animals. Balb/C male mice of 6 to 8 weeks old were obtained from an inbred colony maintained at the Experimental Animal Facility of National Centre for Cell Science (NCCS), Pune, India. Animals were housed under controlled conditions of light (12 h of light and 12 h of darkness), temperature (24°C) and humidity (50%). Mice were maintained on normal chow and water. Experimental protocols were approved by Institutional (NCCS) Animal Ethical Committee.
After 6-8 h of fasting, mice were injected i.p. with freshly prepared streptozotocin (STZ, Sigma Aldrich, St. Louis, MO) (200 mg/kg body weight). Blood from the tail veins of 6-8 h fasted mice, were assessed for the blood glucose (BG) concentrations (EUSURE blood glucose meter, Eumed Biotechnology Co., Ltd., Tiwan) at 24 h of interval to confirm the diabetic status of animals. Body weights were also recorded at the same time. Mice showing BG more than 300 mg/dL were consistently considered diabetic and glucose clearance was impaired.
Encapsulation of ILCs in biocompatible capsule for transplantation in diabetic mice. A biocompatible and immunoisolatory polyurethane-polyvinylpyrrolidone (IP-PV) Semi IPN macrocapsule was used to encapsulate the ILCs for avoidance of immunorejection (Fig. 5A) . The macrocapsules are selectively permeable to glucose and insulin and impermeable to higher molecular weight immunoglobulins. All encapsulation procedures were carried out under strictly aseptic conditions. These capsules were washed thoroughly for 60 days with sterile distilled water followed by sterile phosphate buffered saline (PBS) (pH 7.2) and DMEM medium washed for 24 h each. For transplantation, around 1,000 Islet equivalent clusters (ILCs) were suspended in sodium alginate solution (1.2% w/v Alginic acid; Sigma Chemical Co., USA, in 0.85% saline) in a ratio of 1,000 islets/ml alginate solution. This ILCs containing solution was then transferred in to biocompatible capsule and the open end of the capsule was sealed using heat. The capsule was then washed and transferred using sterile PBS (pH 7.2).
Animals were fasted overnight and anaesthetized by intraperitoneal (i.p.) administration of thiopental sodium at a dose of 40 mg/kg body weight. Around 2 mm long incisions were made
